ICP 监测设备市场：依细分市场划分的规模、占有率、法规、偿付、程序、到2033年的预测

ICP 监测设备是用于测量患有导致脑内压升高的神经系统疾病的患者的颅内压（ICP）的医疗设备。这些神经系统疾病包括创伤性脑损伤、蜘蛛网膜下腔出血、脑积水和脑肿瘤。监测颅内压很重要，因为颅内压升高会导致脑损伤和其他严重併发症。

创伤性脑损伤（TBI）是使用 ICP 监测设备的主要原因。使用 EVD 进行 ICP 监测被认为是黄金标准，因为它允许脑脊髓液引流的额外治疗功能。限制使用 EVD 进行 ICP 监测的因素之一是在心室尺寸较小或脑肿胀的患者中插入 EVD 很困难。此外，长期使用EVD进行ICP监测会增加颅内感染的风险。

本报告深入探讨了全球 ICP 监测设备市场，包括竞争格局、SWOT 分析、到2033年的市场预测以及区域和国家趋势。

目录

目前市面上ICP监测设备及竞争状况

• 对主要产业趋势的见解
• 2015年至2033年 ICP 监测设备各细分市场的市场总收入及市场前景
• 有关单位数量、平均售价和市场价值的详细资料

全球、区域与国家见解

• ICP监测设备市场的SWOT分析
• ICP 监控设备市场的竞争动态洞察与趋势
• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技的监管状况

ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

ICP monitoring devices are medical devices used to measure intracranial pressure (ICP) in patients with neurological conditions that can cause increased pressure in the brain. These neurological conditions may include traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and brain tumors. Monitoring ICP is important because increased pressure in the brain can lead to brain damage and other serious complications.

Traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. ICP monitoring using an EVD is considered as the gold standard as the technique allows an additional therapeutic function of CSF drainage. One factor which limits the use of EVDs for ICP monitoring is the difficulty of inserting the device in patients with small ventricle size or in patients with brain swelling. Also, long term use of EVDs for ICP monitoring increases the risk of intracranial infection.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ICP Monitoring Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total ICP Monitoring Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for ICP Monitoring Devices market.
• Competitive dynamics insights and trends provided for ICP Monitoring Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, Medtronic Plc, Natus Medical Inc, Spiegelberg GmbH & Co KG, Sophysa SA, Raumedic AG, Proteses Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the ICP Monitoring Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving ICP Monitoring Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ICP Monitoring Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific ICP Monitoring Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.